Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 1 (2004), Issue 3 (December)

1. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis.
   Genes Immun, 5(8): 662-7. [Abstract] [Full-text]
2. Nonalcoholic steatohepatitis associated with psoriasis vulgaris.
   J Gastroenterol, 39(11): 1102-5. [Abstract] [Full-text]
3. Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN).
   Am J Hum Genet, 76(1): 164-71. [Abstract] [Full-text]
4. Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin.
   J Am Acad Dermatol, 51(6): 1006-8. [Abstract] [Full-text]
5. Perceived stress, stress attributions and psychological distress in psoriasis.
   J Psychosom Res, 57(5): 465-71. [Abstract] [Full-text]
6. Involvement of the foot in patients with psoriatic arthritis. A review of 26 cases.
   Joint Bone Spine, 71(6): 546-9. [Abstract] [Full-text]
7. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus.
   Ann Hum Genet, 68: 639-45. [Abstract] [Full-text]
8. Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
   Skin Pharmacol Physiol, 18(1): 42-54. [Abstract] [Full-text]
9. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient.
   Br J Dermatol, 151(6): 1227-33. [Abstract] [Full-text]
10. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being.
    Br J Dermatol, 151(6): 1219-26. [Abstract] [Full-text]
11. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
    Arch Dermatol, 140(12): 1490-5. [Abstract] [Full-text]
12. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis.
    J Invest Dermatol, 123(6): 1037-44. [Abstract] [Full-text]
13. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris.
    J Invest Dermatol, 123(6): 1030-6. [Abstract] [Full-text]
14. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Rheumatology (Oxford), 44(1): 126-9. [Abstract] [Full-text]
15. A rare cause of complete heart block after transdermal botanical treatment for psoriasis.
    Pacing Clin Electrophysiol, 27(12): 1686-8. [Abstract] [Full-text]
16. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
    J Am Acad Dermatol, 52(1): 27-31. [Abstract] [Full-text]
17. The prevalence of psoriasis in African Americans: results from a population-based study.
    J Am Acad Dermatol, 52(1): 23-6. [Abstract] [Full-text]
18. Diagnosis and treatment of psoriatic arthritis.
    J Am Acad Dermatol, 52(1): 1-19. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.